Harmonized NCL, EU-NCL & ISO 10993-22 Assay Cascade Matrix

Standardized Preclinical Characterization Tiers · PCC, STE, ITA & TOX Crosswalk

A harmonized nanomedicine assay cascade enforces sequential clearance across physicochemical characterization (PCC), sterility and orthogonal endotoxin testing (STE), in vitro immunotoxicity and complement screening (ITA), and in vivo toxicology (TOX). Running cytotoxicity or cytokine panels before verifying hydrodynamic stability and ISO 29701 spike recovery invalidates downstream IND and EMA regulatory submissions.

Crosswalk compiled from US NCI-NCL, EU-NCL Assay Cascade, and ISO/TR 10993-22.

Gloved researcher loading a quartz cuvette containing translucent nanomaterial dispersion into a dynamic light scattering particle sizer. — 1. Quartz cuvette DLS & zeta-potential verification prior to cell exposure (EUNCL-PCC-01).

2. Borosilicate pyrogen-free serial dilutions preventing plasticizer adsorption.

3. Serum-free vs. 10% FBS hydrodynamic diameter drift logging over 24 hours.

1. Filterable Four-Tier Assay Cascade Table

Filter protocols by cascade tier (PCC, STE, ITA, TOX) to compare NCI-NCL, EU-NCL, Graphene Flagship, and ISO 10993-22 requirements.

Endpoint	NCI-NCL	EU-NCL	Graphene / ISO Gate	Pass Criterion & Artifact Risk
Hydrodynamic Size & PDI	PCC-1	EUNCL-PCC-01	ISO 22412	PDI < 0.25 Check flake sedimentation
Zeta Potential & Surface Area	PCC-2	EUNCL-PCC-02	BET + 3-Desc C:O	Cap 10 cm2/mL Normalize dose by area
Endotoxin Screen (LAL / rFC)	STE-1	EUNCL-STE-01	ISO 29701	50% to 150% PPC 405nm quench on GO
Macrophage TNF-alpha / MAT	STE-4	EUNCL-STE-02	Polymyxin B block	Orthogonal Resolves LAL adsorption
Hemolysis (Human Blood)	ITA-1	EUNCL-ITA-01	ASTM F756	< 5% Lysis Triton X-100 positive ctrl
Complement SC5b-9 / C3a	ITA-5.1	EUNCL-ITA-02	Cremophor EL ctrl	CARPA Watch < 2x vehicle baseline
PBMC Cytokine & M1/M2	ITA-10	EUNCL-ITA-05	CyTOF / scRNA-seq	Donor Panel Run >= 3 healthy donors
Scaffold Leachables & PK	TOX-1	EUNCL-TOX-01	ISO 10993-12	24h/72h Extract Verify ICP-MS & GC-MS

2. Four-Stage Sequential Gate Architecture

Advancing directly from synthesis to animal dosing without passing Gate 01 and Gate 02 accounts for the majority of irreproducible nanotoxicity findings. Each gate requires documented batch stability in the final biological vehicle.

3. Dispersion Vehicle & Batch-to-Batch Drift Controls

Preclinical batches frequently exhibit divergent complement and macrophage responses when dispersion sonication energy or stabilizer concentration shifts between lots. Under EUNCL-PCC-13 and THM-ESATT quantitative criteria, laboratories must archive full acoustic energy density (J/mL), filter sterilization recovery percentages, and endotoxin-free water conductivity logs alongside biological replicates.

Tip vs. Cup-Horn Sonication: Probe-tip sonicators shed titanium micro-particles into carbon dispersions; cup-horn or water-bath sonication in pyrogen-free borosilicate vials prevents metallic interference in ITA-10 macrophage assays.
Sterile Filtration Loss Check: 0.22 um PES or PTFE membranes retain high-aspect-ratio graphene oxide sheets above 500 nm; quantify post-filtration concentration via UV-Vis calibration before computing delivered cm2/mL.
Biological Media Corona Equilibrium: Pre-incubate particles in heat-inactivated vs. active human serum where complement comparison is planned, avoiding heat-inactivation artifacts in ITA-5.1.

Historical Downloads & Links Archive (2018 to 2021, non-affiliated reference)

Historical URLs /downloads and /links on the 2018 to 2021 ESA Topical Team portal indexed five consortium briefing PDFs (Part1.pdf through Part5.pdf, unarchived externally) and partner laboratory links covering tissue regeneration and biosensor platforms. Those legacy entry points resolve here to harmonize archival topical intent with current open-access NCI-NCL, EU-NCL, and ISO 10993-22 characterization standards.